Re: Using Medicare Claims to Examine Long-Term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial Editorial Comment

被引：0
|
作者：
Resnick, Matthew J.
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 200卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：689 / 689
页数：1
相关论文
共 50 条
  • [21] Long-Term Survival of Participants in the Prostate Cancer Prevention Trial
    Thompson, Ian M., Jr.
    Goodman, Phyllis J.
    Tangen, Catherine M.
    Parnes, Howard L.
    Minasian, Lori M.
    Godley, Paul A.
    Lucia, M. Scott
    Ford, Leslie G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (07): : 603 - 610
  • [22] Long-term survival of subjects in the prostate cancer prevention trial
    Goodman, Phyllis J.
    Thompson, Ian Murchie
    Tangen, Catherine M.
    Parnes, Howard L.
    Godley, Paul Alphonso
    Ford, Leslie G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [23] INFLAMMATION IN BENIGN PROSTATE TISSUE AND PROSTATE CANCER IN THE FINASTERIDE ARM OF THE PROSTATE CANCER PREVENTION TRIAL
    Murtola, Teemu
    Gurel, Bora
    Umbehr, Martin
    Lucia, Scott
    Thompson, Ian
    Goodman, Phyllis
    Kristal, Alan
    Parnes, Howard
    Lippman, Scott
    Sutcliffe, Siobhan
    Peskoe, Sarah
    Drake, Charles
    Nelson, William
    De Marzo, Angelo
    Platz, Elizabeth
    JOURNAL OF UROLOGY, 2015, 193 (04): : E27 - E27
  • [24] Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial
    Murtola, Teemu J.
    Gurel, Bora
    Umbehr, Martin
    Lucia, M. Scott
    Thompson, Ian M., Jr.
    Goodman, Phyllis J.
    Kristal, Alan R.
    Parnes, Howard L.
    Lippman, Scott M.
    Sutcliffe, Siobhan
    Peskoe, Sarah B.
    Barber, John R.
    Drake, Charles G.
    Nelson, William G.
    De Marzo, Angelo M.
    Platz, Elizabeth A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (03) : 463 - 469
  • [25] Do the benefits of finasteride outweigh the risks in the prostate cancer prevention trial? Comment
    Thompson, IM
    Klein, EA
    Tangen, CM
    Lippman, S
    JOURNAL OF UROLOGY, 2006, 175 (03): : 938 - 938
  • [26] More on Long-Term Effects of Finasteride on Prostate Cancer Mortality
    Stapff, Manfred P.
    Palm, Stephan
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20):
  • [27] Re: The Prostate Cancer Prevention Trial Risk Calculator and the Relationship between Prostate-Specific Antigen and Biopsy Outcome Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2014, 191 (02): : 360 - 360
  • [28] Re: Radiotherapy to the Prostate for Men with Metastatic Prostate Cancer in the UK and Switzerland: Long-Term Results from the STAMPEDE Randomised Controlled Trial - Editorial Comment
    不详
    JOURNAL OF UROLOGY, 2022, 208 (04): : 931 - 932
  • [29] Re: Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2013, 189 (03): : 902 - 902
  • [30] Re: Long-Term Disease-Specific Functioning Among Prostate Cancer Survivors and Noncancer Controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2013, 189 (02): : 528 - 529
12345